| Neoadjuvant sunitinib facilitates nephron-sparing surgery and ... - UroToday |
|
|
UroTodayBilateral Renal Cell Carcinoma (RCC) is an uncommon clinical entity, affecting 3%-6% of patients with localized RCC. Sunitinib has proven efficacy in the ... read more |